Increasing Demand for Regenerative Medicines Likely to Enhance Primary Cell Culture Product Sales
Primary Cell Culture Market Forecast and CAGR
According to the latest research by Fact.MR., the primary cell culture market is set to witness steady growth during 2021-2031. Increasing demand for primary cell culture due to growing research in tissue culture and tissue engineering will witness stable recovery in the short term, with a promising growth outlook in the long run. Demand for cell culture research is constantly growing all over the world, which anticipated to provide momentum to the primary cell culture market over forecast years.
Request for Sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=6253
What is Driving Demand for Primary Cell Culture?
Growing research to develop novel therapeutics increases the demand for primary cell culture. The research involved in the characterization and isolation of viruses also increases the demand for primary cell culture. Increasing academic life science research activities all over the world on tissue culture also driving the demand for primary cell culture products.
Besides, the increasing prevalence of chronic conditions, such as autoimmune diseases, cancer, diabetes mellitus, chronic infections, nephrological diseases and cardiovascular diseases also continue to be a lucrative avenue for the primary cell culture product manufacturers.
In addition, the global incidence of cancer is on a constant rise. WHO projections suggest that the number of deaths from cancer globally will continue to rise and will reach around 13.1 billion by 2030. It also suggests that global cancer prevalence will increase by around 75% from 2008 to 2030. A rapid growth in incidence of cancer across the globe will lead to an increased demand for novel therapeutics, hence anticipated to propel the primary cell culture market growth over the forecast years.
Increasing Demand for Regenerative Medicines Likely to Enhance Primary Cell Culture Product Sales
The introduction of regenerative medicine to replace damaged tissue or organ in recent years increases cell culture research activities all over the world. Growing focus to understand the biological process & molecular mechanisms of the cell to develop advanced therapies is anticipated to drive the demand for primary cell culture products in the coming years.
Although the life science industry including primary cell culture has been adversely impacted by COVID-19. But with the ongoing COVID-19 pandemic there is an opportunity for researchers and manufacturers to develop new products using primary cell culture to manage the new variants of the virus.
Request for Customization – https://www.factmr.com/connectus/sample?flag=RC&rep_id=6253
US and Canada Primary Cell Culture Market Outlook
The U.S is expected to contribute the largest market revenue share in the North American region than Canada. The U.S. primary cell culture market is likely to set to boom during the forecast period 2021-2031 and this trend is expected to continue over the years. Due to supportive government healthcare research funding, high healthcare expenditure, rising incidence of chronic diseases, and growing geriatric population U.S anticipated as the most lucrative market in the global market.
A strong and prosperous Canadian biomanufacturing sector withgrowing CMOs (contract manufacturing organization) also creates huge opportunities for the manufacturers involved in primary cell culture product developments in this region.
Europe Demand Outlook for Primary Cell Culture
Europe is the largest hub for biotechnology research and having 16 world’s top universities out of 50. Europe is moving at two speed in biotechnology activity. There are hundreds of biopharmaceutical companies are based in Germany, France, and the U.K. Rising government investment in cell culture research and drug developments create a huge growth opportunity for the primary cell culture market in Europe.
In spite of COVID-19 challenges, countries in Europe are likely to maintain a steady healthcare expenditure. According to an OECD report,there is an expectation that the COVID?19 pandemic will increase the health expenditure share of GDP in many European countries in 2020 than in 2019. The healthcare spending across European countries stood on an average at 8.3% of GDP in 2019. It can be expected that the COVID?19 pandemic will lead to an increase in the health spending share of GDP in many countries in 2020, which is also creating opportunities for primary cell culture product manufacturers and suppliers in the long run.
Who are the Key Manufacturers and Suppliers of Primary Cell Culture?
Some of the leading manufacturers and suppliers of primary cell culture include
- Merck KGaA
- Danaher
- Thermo Fisher Scientific Inc.
- Lonza
- Corning Incorporated
- PromoCell GmbH
- FUJIFILM
- Irvine Scientific Inc.
- Axol Bioscience Ltd.
- Mattek
- STEMCELL Technologies Inc.
- HiMedia Laboratories Pvt Ltd
- ATCC
- Others
Manufacturers in this market engaged in several industry development activities such as a merger, acquisition, collaborations to hold their strong position in the global market. For instance, in July 2020 Thermo Fisher Scientific Inc. collaborated with Lyell Immunopharma to develop more effective cell therapies for cancer patients.
Pre-Purchase Enquiry – https://www.factmr.com/connectus/sample?flag=EB&rep_id=6253Key Segments
By Product
- Primary Cells
- Human Primary Cells
- Animal Primary Cells
- Reagents & Supplements
- Media
By Application
- Tissue Culture & Tissue Engineering
- Vaccine Production
- Gene Therapy and Regenerative Medicine
- Virology
- Stem Cell Therapy
- Others
By End User
- Life Science Research Companies
- Research Institutes
By Region
- North America
- The U.S.
- Canada
- Latin America
- Brazil,
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- BENELUX
- Rest of Europe
- South Asia
- India
- Thailand
- Malaysia
- Indonesia
- Rest of South Asia
- East Asia
- China
- Japan
- South Korea
- Oceania
- Australia
- New Zealand
- Middle East and Africa
- GCC Countries
- South Africa
- Turkey
- Rest of MEA
Why choose Fact.MR?
Reports published by Fact.MR are a result of the combination of our experts and digital technologies. We thrive to provide innovative business solutions to the clients as well as tailor the reports aligning with the clients’ requisites. Our analysts perform comprehensive research to offer ins and outs of the current market situation. Clients across various time zones tend to utilize our 24/7 service availability.
Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:
Fluoro Enzymatic Assays Market – https://www.factmr.com/report/fluoro-enzymatic-assays-market
Shower Chairs Market – https://www.factmr.com/report/shower-chairs-market
Infrared Thermometer Market – https://www.factmr.com/report/infrared-thermometer-market
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
136 Sejong-daero
Level 21
Seoul, 100-768
South Korea
E-Mail: sales@factmr.com
The post Increasing Demand for Regenerative Medicines Likely to Enhance Primary Cell Culture Product Sales appeared first on Latest Market Reports.
Editor Details
-
Company:
- MARKITWIRED Latest Market Reports
- Website:
